Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Breast 3Sarcoma 2Other hematologic neoplasm 2Head & Neck 2Other neoplasm 1Myeloid 1Classical hematology 1

Conditions

Head and Neck Neoplasms 1870Squamous Cell Carcinoma of Head and Neck 1109Nasopharyngeal Carcinoma 535Thyroid Neoplasms 519Mouth Neoplasms 347Oropharyngeal Neoplasms 292Laryngeal Neoplasms 197Carcinoma, Squamous Cell 188Neoplasms 187Breast Neoplasms 183Lung Neoplasms 182Nasopharyngeal Neoplasms 160Thyroid Nodule 154Salivary Gland Neoplasms 135Thyroid Cancer, Papillary 122Neoplasm Metastasis 113Carcinoma, Non-Small-Cell Lung 113Hypopharyngeal Neoplasms 111Melanoma 105Prostatic Neoplasms 99Esophageal Neoplasms 95Colorectal Neoplasms 90Thyroid Diseases 87Uterine Cervical Neoplasms 82Recurrence 81Pancreatic Neoplasms 79Ovarian Neoplasms 70Sarcoma 68Stomach Neoplasms 65Xerostomia 62

Interventions

parathyroid hormone-related peptide (1-36) 2Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Musculoskeletal Diseases × Head & Neck × Clear all
NCT00580788 2016-02-11

One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

University of Pittsburgh

Phase EARLY_PHASE1 Completed
14 enrolled 16 charts
Head & Neck

Humoral Hypercalcemia Of Malignancy, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Neoplasms, Osteoporosis

NCT01333267 2014-12-05

One Week Comparison Study of PTH and PTHrP Infusions

University of Pittsburgh

Phase 1 Withdrawn
Head & Neck

Humoral Hypercalcemia Of Malignancy, Bone Diseases, Endocrine, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡